135 related articles for article (PubMed ID: 31135963)
1. Adalimumab-induced erythrodermic reactions.
Nowsheen S; Kohorst JJ; El-Azhary RA
Int J Dermatol; 2019 Oct; 58(10):e204-e206. PubMed ID: 31135963
[No Abstract] [Full Text] [Related]
2. A case of erythrodermic psoriasis in which adalimumab injection sites are preserved.
Ozcan I; Karadag AS; Ceren E; Demirci B; Cebeci F
Dermatol Ther; 2021 Mar; 34(2):e14865. PubMed ID: 33569858
[No Abstract] [Full Text] [Related]
3. Erythrodermic psoriasis and secukinumab: Our clinical experience.
Mateu-Puchades A; Santos-Alarcón S; Martorell-Calatayud A; Pujol-Marco C; Sánchez-Carazo JL
Dermatol Ther; 2018 Jul; 31(4):e12607. PubMed ID: 29663615
[No Abstract] [Full Text] [Related]
4. Erythrodermic psoriasis peculiarly sparing anti-TNF injection sites in a patient with secondary loss of efficacy.
Kapoor DM; Tan KW
Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 28976682
[No Abstract] [Full Text] [Related]
5. Exfoliative erythroderma after tumor necrosis factor-α inhibitor therapy.
el-Azhary RA; Lehman JS
Int J Dermatol; 2016 Apr; 55(4):e214-5. PubMed ID: 26917358
[No Abstract] [Full Text] [Related]
6. Paradoxical case effects of psoriasis following adalimumab therapy: A case series.
Zangrilli A; Bavetta M; Mazzilli S; Garofalo V; Bianchi L
Dermatol Ther; 2018 Nov; 31(6):e12729. PubMed ID: 30239070
[No Abstract] [Full Text] [Related]
7. Long-term remission induced by secukinumab in a 13-year-old boy having recalcitrant chronic erythrodermic psoriasis.
Dogra S; Bishnoi A; Narang T; Handa S
Dermatol Ther; 2018 Jul; 31(4):e12611. PubMed ID: 29687662
[No Abstract] [Full Text] [Related]
8. Trimethoprim-sulfamethoxazole induced erythrodermic psoriasis.
Esposito M; Saraceno R; Schipani C; Di Marcantonio D; Bianchi L; Chimenti S
J Infect; 2008 Jul; 57(1):90-2. PubMed ID: 18499260
[No Abstract] [Full Text] [Related]
9. Ustekinumab in severe complicated erythrodermic psoriasis: rapid clearing, safety, and sustained remission.
Koutsoukou XA; Papadavid E; Theodoropoulos K; Rigopoulos D
Dermatol Ther; 2014; 27(5):257-9. PubMed ID: 24813816
[TBL] [Abstract][Full Text] [Related]
10. Treatment of erythrodermic psoriasis in HCV+ patient with adalimumab.
Richetta AG; Maiani E; Carlomagno V; Carboni V; Mattozzi C; Giancristoforo S; Calvieri S
Dermatol Ther; 2009 Nov; 22 Suppl 1():S16-8. PubMed ID: 19891686
[TBL] [Abstract][Full Text] [Related]
11. The development of chronic inflammatory demyelinating polyneuropathy during adalimumab treatment in a patient with psoriasis vulgaris.
Nakao M; Asano Y; Nakamura K; Shida R; Takahashi T; Yoshizaki A; Mitsui A; Shibata S; Araki M; Watanabe R; Ikawa Y; Toyoda C; Oka H; Sato S
Eur J Dermatol; 2016 Aug; 26(4):404-5. PubMed ID: 27086491
[No Abstract] [Full Text] [Related]
12. Erythrodermic psoriasis successfully treated with efalizumab.
Piccirillo F; Stinco G; Patrone P
Eur J Dermatol; 2008; 18(3):357-8. PubMed ID: 18474483
[No Abstract] [Full Text] [Related]
13. Exfoliative dermatitis after long-term methotrexate treatment of severe psoriasis.
Peters T; Theile-Ochel S; Chemnitz J; Söhngen D; Hunzelmann N; Scharffetter-Kochanek K
Acta Derm Venereol; 1999 Sep; 79(5):391-2. PubMed ID: 10494723
[No Abstract] [Full Text] [Related]
14. A case of concurrent psoriasis and ulcerative colitis with development of arthritis during adalimumab treatment.
Toyama S; Kanda H; Tateishi S; Yamada A; Sato S; Asano Y
Eur J Dermatol; 2019 Dec; 29(6):651-653. PubMed ID: 31806587
[No Abstract] [Full Text] [Related]
15. Guillain-Barré syndrome in a patient on adalimumab for the treatment of psoriasis.
Natividade NB; Felix PAO; Lerer C
An Bras Dermatol; 2017; 92(5 Suppl 1):85-87. PubMed ID: 29267456
[TBL] [Abstract][Full Text] [Related]
16. Psoriasiform dermatitis in a non-psoriatic patient treated with adalimumab.
Tammaro A; Persechino S; Abruzzese C; Narcisi A; Cortesi G; Parisella FR; Laganà B
Int J Immunopathol Pharmacol; 2012; 25(2):499-501. PubMed ID: 22697082
[TBL] [Abstract][Full Text] [Related]
17. Erythrodermic psoriasis associated with hyperuricemia and Iatrogenic Cushing's syndrome due to topical corticosteroid therapy.
Ohnishi T; Suzuki T; Watanabe S; Takahashi H
Int J Dermatol; 1996 May; 35(5):379-80. PubMed ID: 8734668
[No Abstract] [Full Text] [Related]
18. Erythroderma in a patient taking acitretin for plaque psoriasis.
Ahdout J; Mandel H; Chiu M
J Drugs Dermatol; 2008 Apr; 7(4):391-4. PubMed ID: 18459522
[TBL] [Abstract][Full Text] [Related]
19. Mycobacterium marinum infection contracted from seaweed wrap in a psoriasis patient undergoing treatment with adalimumab.
Timoney I; Lynch M; Timoney L; Feeney E; Kirby B
Dermatol Online J; 2017 Aug; 23(8):. PubMed ID: 29469748
[TBL] [Abstract][Full Text] [Related]
20. Concurrent development of psoriatic arthritis, drug-induced interstitial pneumonia, and increased anti-nuclear antibodies in a patient with psoriasis vulgaris undergoing adalimumab treatment.
Yasuda M; Morimoto N; Yonemoto Y; Sunaga N; Ishikawa O
Eur J Dermatol; 2019 Feb; 29(1):81-82. PubMed ID: 30530442
[No Abstract] [Full Text] [Related]
[Next] [New Search]
